article thumbnail

IAM's Role in the Pharmaceutical Sector

Data Breach Today

Sandy Dalal of Allergan on Achieving Security Stability Mergers and acquisitions, along with cloud adoption, are rapidly changing the pharmaceutical industry. Sandy Dalal of Allergan talks about how identity and access management, along with zero trust, are bringing security stability.

article thumbnail

Pharma Industry Seeing Reduction in Data Breach Costs, But Still Have Much to Do

KnowBe4

Insights from IBM’s Cost of a Data Breach Report on the Pharmaceutical Industry shows that while the overall cost has improved, there are clear areas of risk that need to be addressed.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Merck's Success Story: Boosting Efficiency With RPA and Bots

Data Breach Today

Learn how this technology revolutionized their workflow and what it mean for the future of the pharmaceutical industry. How Merck Used Bots to Assist With Regulatory Filings in 23 Geographies Discover how Merck, a traditional global pharma giant, achieved efficiency by embracing RPA and bots for regulatory documentation.

article thumbnail

Healthcare Summit: Securing Life Sciences, Genomic Data

Data Breach Today

ISMG Summit Speaker Phil Englert of H-ISAC on Emerging Security Healthcare Issues Life sciences firms, including pharmaceutical companies, are facing growing challenges in securing complex sets of sensitive data, including genomic information, said H-ISAC's Phil Englert, one of many high-profile speakers who will discuss industry trends at ISMG's upcoming (..)

article thumbnail

Identity Verification in Healthcare: Revamping a Framework

Data Breach Today

A 15-year-old identity framework originally designed for narrow use by pharmaceutical companies is being revamped and updated for broader use in healthcare, says Kyle Neuman, managing director of SAFE Identity, an industry consortium and certification body that's coordinating the project.

article thumbnail

AI Use in Drug Discovery

Data Matters

Together, they discuss the challenges and opportunities AI presents for the pharmaceutical industry, particularly how AI is accelerating the pace of drug discovery and its implications for the future of medicine. Join “State of the Art” host and Sidley partner Stephen Abreu as he speaks with Colin Hill , CEO and Co-Founder of Aitia.

article thumbnail

Delivering responsible AI in the healthcare and life sciences industry

IBM Big Data Hub

Created by a respected Tennessee pharmaceutical firm, Elixir Sulfanilamide was a liquid medication touted to dramatically cure strep throat. Learn how to weave responsible AI governance into the fabric of your business The post Delivering responsible AI in the healthcare and life sciences industry appeared first on IBM Blog.